Scinovex
review Open AccessTop 1% cited

Applications of nanoparticles in biomedical imaging

Nanoscale · 2018 · Vol. 11(3) · pp. 799–819
Xiangjun HanKe XuOlena TaratulaKhashayar Farsad

Abstract

An urgent need for early detection and diagnosis of diseases continuously pushes the advancements of imaging modalities and contrast agents. Current challenges remain for fast and detailed imaging of tissue microstructures and lesion characterization that could be achieved via development of nontoxic contrast agents with longer circulation time. Nanoparticle technology offers this possibility. Here, we review nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT, addressing their structure related features, advantages and limitations. Furthermore, their applications in each imaging modality are also reviewed using commonly studied examples. Future research will investigate multifunctional nanoplatforms to address safety, efficacy and theranostic capabilities. Nanoparticles as imaging contrast agents have promise to greatly benefit clinical practice.

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryPhotoacoustic and Ultrasonic ImagingNanotechnologyModalitiesContrast (vision)NanoparticleClinical imagingMedical imagingClinical PracticeMaterials scienceMedical physicsComputer science

MeSH terms

AnimalsContrast MediaHumansMagnetic Resonance ImagingNeoplasmsTomography, X-Ray ComputedUltrasonographyPositron-Emission TomographyNanoparticlesOptical Imaging

Funding

  • National Natural Science Foundation of China
  • National Center for Advancing Translational Sciences
Citations
600
FWCI
16.88
field-weighted impact
References
252
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.